Piodar

Piodar

Tablet

🧬 Pioglitazone 🏢 Incepta Pharmaceuticals Ltd.
Generic Name Pioglitazone
Manufacturer Incepta Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00) Strip Price: ৳ 80.00

🔹 Indications

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Pharmacology

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Dosage & Administration

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Interaction

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Contraindications

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Side Effects

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Pregnancy & Lactation

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Precautions & Warnings

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

🔹 Storage Conditions

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when diet and exercise plus the single agent does not result in adequate glycaemic control.

💡 Frequently Asked Questions

Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when...
Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when...
Piodar is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type II diabetes (NIDDM). Piodar is indicated for monotherapy and also indicated for use in combination with sulphonylurea, Metformin or Insulin when...

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review